138 related articles for article (PubMed ID: 4909251)
21. [L-asparaginase in the treatment of leukemia].
Astaldi G; Burgio GR; Severi F; Genova R; Curtini E; Bruschelli M; Astaldi A
Przegl Lek; 1971; 27(3):286-9. PubMed ID: 5280473
[No Abstract] [Full Text] [Related]
22. [Amino acid concentration in plasma and blood cells during coli-L-asparaginase therapy].
Höcker P; Stacher A; Weiser M
Blut; 1972 Jul; 25(1):9-19. PubMed ID: 4505116
[No Abstract] [Full Text] [Related]
23. [Preliminary results of the clinical study of a Soviet--produced L-asparaginase from E. coli].
Kondrat'eva NA; Lorie IlI ; Kruglova GV; Vorob'ev AI; Koshel' IV
Antibiotiki; 1977 Sep; 22(9):852-7. PubMed ID: 334060
[No Abstract] [Full Text] [Related]
24. Clinical experience with L-asparaginase.
Hamilton-Fairley G; Malpas JS; Galton DA
Recent Results Cancer Res; 1970; 33():257-62. PubMed ID: 4949164
[No Abstract] [Full Text] [Related]
25. Toxic and therapeutic effects of methotrexate-folinic acid (Leucovorin) in advanced cancer and leukemia.
Vogler WR; Jacobs J
Cancer; 1971 Oct; 28(4):894-901. PubMed ID: 5315548
[No Abstract] [Full Text] [Related]
26. L-asparaginase treatment of acute myeloblastic leukemia.
Hansen HH; Canellos GP
Oncology; 1970; 24(5):349-57. PubMed ID: 5275037
[No Abstract] [Full Text] [Related]
27. A summary of the clinical status of asparaginase.
Burchenal JH
Recent Results Cancer Res; 1970; 33():350-4. PubMed ID: 5292724
[No Abstract] [Full Text] [Related]
28. Effect of L-asparaginase therapy upon serum pseudocholinesterase and ceruloplasmin levels in patients with acute leukemia.
Cucuianu M; Bornuz F; Macavei I
Clin Chim Acta; 1972 Apr; 38(1):97-102. PubMed ID: 4503714
[No Abstract] [Full Text] [Related]
29. [L-asparaginase in the treatment of acute leukoses].
Storti E; Fontana G; Ascari E; Lusvarghi E; Silingardi V; Quaglino D; Sgandurra A; Barbieri U; Traldi A
Minerva Med; 1970 Sep; 61(71):3635-42. PubMed ID: 5271737
[No Abstract] [Full Text] [Related]
30. A phase I and pharmacodynamic evaluation of polyethylene glycol-conjugated L-asparaginase in patients with advanced solid tumors.
Taylor CW; Dorr RT; Fanta P; Hersh EM; Salmon SE
Cancer Chemother Pharmacol; 2001; 47(1):83-8. PubMed ID: 11221967
[TBL] [Abstract][Full Text] [Related]
31. Favorable remission induction rate with twice weekly doses of L-asparaginase.
Jaffe N; Traggis D; Das L; Frauenberger G; Hann HW; Kim BS; Bishop Y
Cancer Res; 1973 Jan; 33(1):1-4. PubMed ID: 4565907
[No Abstract] [Full Text] [Related]
32. [L-asparaginase in blast leukemia].
Georgiev Z; Genova V; Avramova D
Vutr Boles; 1973; 12(6):25-37. PubMed ID: 4522152
[No Abstract] [Full Text] [Related]
33. In vivo effects of intraperitoneally injected L-asparaginase solution and L-asparaginase immobilized within semipermeable nylon microcapsules with emphasis on blood L-asparaginase, 'body' L-asparaginase, and plasma L-asparagine levels.
Siu Chong ED; Chang TM
Enzyme; 1974; 18(3):218-39. PubMed ID: 4601662
[No Abstract] [Full Text] [Related]
34. [The L-asparaginase in the treatment of leukemias].
Rass Int Clin Ter; 1971 Feb; 51(4):247-8. PubMed ID: 5280729
[No Abstract] [Full Text] [Related]
35. Asparaginase in acute leukaemia.
Colebatch JH; Matthews RN; Gordon PM; Tan CL; Santamaria JN; Lay HN
Med J Aust; 1970 Feb; 1(6):282. PubMed ID: 5266297
[No Abstract] [Full Text] [Related]
36. [Treatment of acute leukemia with the L-asparaginase. Preliminary results based on 84 cases].
Bernard J; Jacquillat C; Boiron M; Weil M; Bussel A; Larrieu MJ; Delobel J; Goguel A; Levy D; Tanzer J
Presse Med (1893); 1970 Jan; 78(4):161-6. PubMed ID: 5264814
[No Abstract] [Full Text] [Related]
37. L-asparaginase: therapeutic and toxic effects in patients with neoplastic disease.
Haskell CM; Canellos GP; Leventhal BG; Carbone PP; Block JB; Serpick AA; Selawry OS
N Engl J Med; 1969 Nov; 281(19):1028-34. PubMed ID: 4898857
[No Abstract] [Full Text] [Related]
38. Drugs in the treatment of leukemia.
Br Med J; 1968 Nov; 4(5626):305-7. PubMed ID: 5246597
[No Abstract] [Full Text] [Related]
39. Result of a cooperative study with L-asparaginase in human leukemias. Report of the section "oncology" of the Paul-Ehrlich-Society for Chemotherapy.
Gerhartz H; Begemann H
Recent Results Cancer Res; 1970; 33():244-56. PubMed ID: 5292719
[No Abstract] [Full Text] [Related]
40. Pharmacologic studies in man with crystallized L-asparaginase (NSC-109229).
Haskell CM; Canellos GP; Cooney DA; Hardesty CT
Cancer Chemother Rep; 1972 Oct; 56(5):611-4. PubMed ID: 4569055
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
